-
1 Comment
The Joint Corp is currently in a long term uptrend where the price is trading 100.7% above its 200 day moving average.
From a valuation standpoint, the stock is 99.1% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 11.6.
The Joint Corp's total revenue rose by 22.8% to $17M since the same quarter in the previous year.
Its net income has increased by 723.1% to $11M since the same quarter in the previous year.
Finally, its free cash flow grew by 47.3% to $2M since the same quarter in the previous year.
Based on the above factors, The Joint Corp gets an overall score of 5/5.
| ISIN | US47973J1025 |
|---|---|
| CurrencyCode | USD |
| Industry | Medical Care Facilities |
| Sector | Healthcare |
| Exchange | NASDAQ |
| Dividend Yield | None |
|---|---|
| Target Price | 16.375 |
| Beta | 1.46 |
| Market Cap | 151M |
The Joint Corp. operates and franchises chiropractic clinics in the United States. The company was incorporated in 2010 and is headquartered in Scottsdale, Arizona.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for JYNT using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
